Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis

  • Slides: 43
Download presentation
Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division

Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical Director, Loyola Hospice

General Principles Assess pain thoroughly Know your patient Know the medications Dose to reduce

General Principles Assess pain thoroughly Know your patient Know the medications Dose to reduce pain by at least 50% Reassess frequently

Pain is a personal, complex experience with 3 components n n n Sensory Emotional

Pain is a personal, complex experience with 3 components n n n Sensory Emotional Cognitive

Review Neuroscience lectures on pain physiology! P&T lectures on NSAIDs and opiates!

Review Neuroscience lectures on pain physiology! P&T lectures on NSAIDs and opiates!

Pain pathophysiology Acute pain n n identified event, resolves days–weeks usually nociceptive Chronic pain

Pain pathophysiology Acute pain n n identified event, resolves days–weeks usually nociceptive Chronic pain n cause often not easily identified, multifactorial indeterminate duration nociceptive and / or neuropathic Nociceptive pain – results from actual or potential tissue damage. Result of ongoing activation of nociceptors on primary afferent nerves by noxious stimuli Somative vs visceral

WHO 3 -Step Ladder Step 3 - Severe Step 2 - Moderate Codeine/… Morphine

WHO 3 -Step Ladder Step 3 - Severe Step 2 - Moderate Codeine/… Morphine Hydromorphone Step 1 - Mild Hydrocodone/… Methadone Aspirin Oxycodone/… Oxycodone …/acetaminophenor Fentanyl Acetaminophen NSAIDs NSAID Tramadol Always consider adding an adjuvant Rx

“Adjuvant Analgesic” Drug which has a primary indication other than pain management Acts as

“Adjuvant Analgesic” Drug which has a primary indication other than pain management Acts as analgesic in some painful conditions n n n n Antidepressants Corticosteroids Anticonvulsants Local anesthetics Osteoclast inhibitors Radiopharmaceuticals Muscle relaxants Benzodiazepenes

Our Case • • Continuous pain Moderate intensity Chronic, non-neuropathic Worsens with certain activites

Our Case • • Continuous pain Moderate intensity Chronic, non-neuropathic Worsens with certain activites

Where to begin? • Begin low dose immediate release oral opioid • Examples •

Where to begin? • Begin low dose immediate release oral opioid • Examples • • Hydrocodone 5 mg Morphine 5 mg Oxycodone 3 mg Hydromorphone 1 mg Hospice and Palliative Care Training for Physicians: UNIPAC 3 Assessment and Treatment of Physical Pain Associated with Life. Limiting Illness, CP Storey et al, ed EPERC, Fast Facts

Community Service Announcement

Community Service Announcement

Opioids vs Narcotics Opioid n Naturally occurring, semisynthetic, and synthetic drugs which produce effects

Opioids vs Narcotics Opioid n Naturally occurring, semisynthetic, and synthetic drugs which produce effects by combining with opioid receptors and antagonized by nalaxone Narcotic n n “numbness” or “stupor” Describes morphine like drugs and drugs of abuse (including coca/cocaine derivates)

Opioids vs Narcotics “Who’s got the narc keys? ” “Who’s got the opioid keys?

Opioids vs Narcotics “Who’s got the narc keys? ” “Who’s got the opioid keys? ”

Immediate Release Oral Opioid Administered as n n single agents combination products Peak analgesic

Immediate Release Oral Opioid Administered as n n single agents combination products Peak analgesic effect occurs in 60 -90 minutes Expected total duration of analgesia of 2 -4 hours. Standard reference sources generally cite a 4 hour dosing interval for the single-agent opioids n 4 -6 or 6 hour intervals for combination products Agency for Health Care Policy and Research (AHCPR) Clinical Practice Guideline (1994) recommends dosing intervals for all short-acting opioids at an interval or every 3 -4 hours, an interval more consistent with patient reports of pain relief and the half-life of oral opioids.

Combination opiate/nonopiate -50 different opioid combination products • • • Contain either acetaminophen, aspirin

Combination opiate/nonopiate -50 different opioid combination products • • • Contain either acetaminophen, aspirin or ibuprofen, with an opioid range of tablet strengths and liquids typically used for moderate pain that is episodic • For persistent pain administered on around-theclock basis

Step 2 Opioid Combos Potency n Oxycodone > hydrocodone > codeine Propoxyphene = aspirin

Step 2 Opioid Combos Potency n Oxycodone > hydrocodone > codeine Propoxyphene = aspirin or acetaminophen The dose limiting property of all the combination products is? n aspirin, acetaminophen or NSAID

WHO Step 2 Tramadol Centrally acting synthetic analgesic n n n m-opioid receptor binding

WHO Step 2 Tramadol Centrally acting synthetic analgesic n n n m-opioid receptor binding Weak inhibition of serotonin uptake Weak inhibition of norepinephrine uptake Cautions: n n Serotonin syndrome Lowers seizure threshold

Our patient On Percocet n Combination opioid/nonopioid Oxycodone/acetaminophen Strengths n n n 2. 5/325

Our patient On Percocet n Combination opioid/nonopioid Oxycodone/acetaminophen Strengths n n n 2. 5/325 7. 5/500 10/325 10/650

Initial Plan Oxycodone/acetaminophen n 2. 5/325 q 6 hours Not helping - still 5

Initial Plan Oxycodone/acetaminophen n 2. 5/325 q 6 hours Not helping - still 5 -6/10 pain n Titration Increase 25 -50% for mild-moderate pain Increase 50 -100% for moderate – severe pain n Most short acting opiates can be safely titrated every 2 hours Side effect evaluation Sedation

EPIC In-Box Oxycodone/acetaminophen • 5/325 tab • 1 -2 tabs every 6 hours as

EPIC In-Box Oxycodone/acetaminophen • 5/325 tab • 1 -2 tabs every 6 hours as needed

Case Options? Increase dose of oxycodone/acetaminophen? n 10/325 tabs – take 1 ½, not

Case Options? Increase dose of oxycodone/acetaminophen? n 10/325 tabs – take 1 ½, not relieved, take 2 Change dosing interval? n Q 4 hours Scheduled vs PRN dosing? n Scheduled Change to another opiate combo? n Oxycodone most potent Change to non-combo opiate? n Soon - reaching acetaminophen max Add breakthrough dose of opiate? n Yes, but will need an agent without acetaminophen Add an adjuvant? n Re-evaluarte characteristics of pain Begin long acting opiate? n When stable daily dosage requirements determined

Plan Oxycodone 10/325 n n 1 1/2 tabs q 4 hours scheduled 2 days

Plan Oxycodone 10/325 n n 1 1/2 tabs q 4 hours scheduled 2 days later, a little better, not sleepy 2 tabs q 4 hours scheduled Titrated oxycodone from 40 mg /24 hours to 120 mg/24 hours (acetaminophen 3900 mg/24 hours) Relief!!

Q 4 hour ATC meds?

Q 4 hour ATC meds?

Extended-release opiate preparations Improve compliance, adherence

Extended-release opiate preparations Improve compliance, adherence

Extended Release Opiates NEVER!!!!! In opiate naïve patients!!!!!

Extended Release Opiates NEVER!!!!! In opiate naïve patients!!!!!

Extended Release Preparations Extended Release Oral Morphine Extended Release Oral Oxycodone Transdermal Fentanyl

Extended Release Preparations Extended Release Oral Morphine Extended Release Oral Oxycodone Transdermal Fentanyl

Extended-release opiate preparations Morphine n Morphine ER, MS Contin, Kadian, Avinza Oxycodone n Oxycodone

Extended-release opiate preparations Morphine n Morphine ER, MS Contin, Kadian, Avinza Oxycodone n Oxycodone ER, Oxycontin Fentanyl n Transderm patch (Duragesic)

Extended-release opioid preparations Dose q 8, 12, or 24 h (product specific) n n

Extended-release opioid preparations Dose q 8, 12, or 24 h (product specific) n n Don’t crush or chew capsules No capsules down feeding tubes may flush time-release granules (Kadian) down feeding tubes Adjust dose q 2– 4 days (once steady state reached) Fentanyl transderm q 72 hours n Adjust dose at 6 days (once steady state achieved)

Extended-release opioid preparations Should not be used for rapid titration in patients with severe

Extended-release opioid preparations Should not be used for rapid titration in patients with severe pain

Case - How? Oxycodone 10/325 n 2 tabs q 4 hours 120 mg oxycodone/24

Case - How? Oxycodone 10/325 n 2 tabs q 4 hours 120 mg oxycodone/24 hours Oxycodone ER 60 mg q 12 hours

Could we use extended release morphine? Could we use transdermal fentanyl?

Could we use extended release morphine? Could we use transdermal fentanyl?

Fentanyl Lipid soluble -Crosses skin and oral mucosa Transdermal fentanyl n 25 mg patch

Fentanyl Lipid soluble -Crosses skin and oral mucosa Transdermal fentanyl n 25 mg patch 45– 135 (likely 50– 60) mg PO morphine / 24 h 12 mg patch is available now

Fentanyl Transdermal Patch onset after application 24 hours effect 72 hours (some patients 48

Fentanyl Transdermal Patch onset after application 24 hours effect 72 hours (some patients 48 hours) ensure adherence to skin increased absorption with increased body temp may not be as effective in cachexia (minimal adipose tissue)

Our patient Convert to Fentanyl n Oxycodone 120 mg/24 hours

Our patient Convert to Fentanyl n Oxycodone 120 mg/24 hours

Equianalgesic doses of opioid analgesics po / pr (mg) Analgesic SC / IV /

Equianalgesic doses of opioid analgesics po / pr (mg) Analgesic SC / IV / IM (mg) 100 15 4 15 10 Codeine 60 Hydrocodone Hydromorphone 1. 5 Morphine 5 Oxycodone -

Conversion Oxycodone 120 mg x Morphine 15 mg Oxycodone 10 mg =180 mg morphine

Conversion Oxycodone 120 mg x Morphine 15 mg Oxycodone 10 mg =180 mg morphine equivalent n 25 mg patch 50 mg PO morphine / 24 h Fentanyl 75 mcg/hr patch q 72 hrs

Breakthrough Pain Incident n Activity related, identifiable precipitant Anticipate and premedicate with short acting

Breakthrough Pain Incident n Activity related, identifiable precipitant Anticipate and premedicate with short acting agents Idiopathic, spontaneous n n Unpredictable PRN opiate, consider adjuvant End-of-dose failure n Increase dose or shorten time between doses of longacting agent

Breakthrough Pain Use immediate-release opioids n n 10%– 15% of 24 -hr dose offer

Breakthrough Pain Use immediate-release opioids n n 10%– 15% of 24 -hr dose offer after Cmax reached po n q 1 hr or 50% regular 4 hour dose Do NOT use extended-release opioids

Our Case Oxycodone 120 mg/24 hours n 10 -15% Oxycodone 15 mg PO q

Our Case Oxycodone 120 mg/24 hours n 10 -15% Oxycodone 15 mg PO q 1 hour PRN breakthrough pain

Follow-up Oxycodone ER 120 mg q 12 hours Oxycodone 15 mg breakthrough n n

Follow-up Oxycodone ER 120 mg q 12 hours Oxycodone 15 mg breakthrough n n 3 weeks later EPIC in-box Has taken 4 breakthrough doses daily x 2 days Re-evaluate pain 60 mg additional oxycodone Increase oxycodone ER to n 150 mg q 12 hours New breakthrough dose? n Oxycodone 30 mg q 1 hours PRN

Bowel regimen

Bowel regimen

Final Thoughts Physical pain is the most common source of “suffering”

Final Thoughts Physical pain is the most common source of “suffering”

Total Pain Dame Cicely Saunders Physical Emotional Social Spiritual

Total Pain Dame Cicely Saunders Physical Emotional Social Spiritual

Questions?

Questions?